ALECENSA vs IBRANCE

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 20, 2026·How we rate

Possible drug interaction. ALECENSA and IBRANCE are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	ALECENSA	IBRANCE
Rating	New	64/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	ALECTINIB HYDROCHLORIDE	PALBOCICLIB
Manufacturer	Hoffmann La Roche	Pfizer
Dosage forms	Capsule	Capsule, Tablet
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	None	None
Treats	Non-Small-Cell Lung Carcinoma	Breast Neoplasms

alecensa ibrance

Rating

New

64/100

Pharmacy pays

—

Type

Active ingredient

ALECTINIB HYDROCHLORIDE

PALBOCICLIB

Manufacturer

Hoffmann La Roche

Pfizer

Dosage forms

Capsule

Capsule, Tablet

Drug class

Kinase Inhibitor

Boxed warning

None

Treats

Non-Small-Cell Lung Carcinoma

Breast Neoplasms

Frequently asked questions

What is the difference between Alecensa and Ibrance?

Alecensa contains Alectinib Hydrochloride, while Ibrance contains Palbociclib — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.